Tech Company Financing Transactions
Second Genome Funding Round
Second Genome closed a $2.5 million investment round on 6/30/2012. Investors included Advanced Technology Ventures and Morgenthaler Ventures.
Transaction Overview
Company Name
Announced On
6/30/2012
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Undisclosed
Investors
Advanced Technology Ventures (Michael Carusi)
Morgenthaler Ventures (Jason Lettmann)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
341 Allerton Ave.
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Founded in 2009 by leading experts in microbial research, molecular diagnostics, and biotechnology R&D, Second Genome is using its proprietary Microbiome Signature Discovery platform to generate novel insights relating the microbiome with a wide range of human health disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Glenn Nedwin
Chief Medical Officer
Matthew McClure
Chief Scientific Officer
Karim Dabbagh
Vice President
Todd DeSantis
VP - Bus. Development
Anu Hoey
VP - Finance
Brian Dowd
VP - Human Resources
James Sjoerdsma
Browse more venture capital transactions:
Prev: 6/30/2012: Stretch venture capital transaction
Next: 6/30/2012: SafeOp Surgical venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs